Zabezhinski, Inhibitory effect of peptide Epitalon on colon carcinogenesis induced by 1,2-dimethylhydrazine in rats
Gastrointestinal symptoms: Some peptides, especially GLP-1 receptor agonists such as semaglutide or tirzepatide, can slow digestion, which may lead to nausea, vomiting, diarrhea, or constipation
An error in reconstitution, using too much or too little bacteriostatic water , cascades through every subsequent dose
Robert Glatter, MD, an emergency physician at Lenox Hill Hospital in New York City and assistant professor at Zucker School of Medicine, told Healthline that these findings support the idea that some patients may have partial biologic resistance to incretin-based therapies. He added that genetics explains only part of the treatment differences and that routine pharmacogenomic screening is not yet ready for widespread clinical use. The same article noted that this PAM research looked at bloodsugar control, not weight loss, and GLP1 drugs are typically prescribed at higher doses for obesity than for diabetes
Janet Tomiyama, a UCLA psychologist, wrote in the January Annals of Behavioral Medicine
*You agree to be contacted by Emerson Medical by submitting this form